Detailed information for compound 1445718

Basic information

Technical information
  • TDR Targets ID: 1445718
  • Name: 4-[[(4-methylphenyl)sulfonylamino]methyl]-N-( 2-phenylethyl)cyclohexane-1-carboxamide
  • MW: 414.561 | Formula: C23H30N2O3S
  • H donors: 2 H acceptors: 3 LogP: 3.95 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(cc1)S(=O)(=O)NCC1CCC(CC1)C(=O)NCCc1ccccc1
  • InChi: 1S/C23H30N2O3S/c1-18-7-13-22(14-8-18)29(27,28)25-17-20-9-11-21(12-10-20)23(26)24-16-15-19-5-3-2-4-6-19/h2-8,13-14,20-21,25H,9-12,15-17H2,1H3,(H,24,26)
  • InChiKey: XVJKMXGSXSWIGT-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 4-[[(4-methylphenyl)sulfonylamino]methyl]-N-(2-phenylethyl)-1-cyclohexanecarboxamide
  • EU-0099564
  • K938-0821
  • NCGC00127281-01

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references
Homo sapiens microtubule-associated protein tau Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Echinococcus granulosus microtubule associated protein 2 Get druggable targets OG5_133504 All targets in OG5_133504
Schistosoma japonicum ko:K04380 microtubule-associated protein tau, putative Get druggable targets OG5_133504 All targets in OG5_133504
Schistosoma mansoni microtubule-associated protein tau Get druggable targets OG5_133504 All targets in OG5_133504
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Echinococcus multilocularis microtubule associated protein 2 Get druggable targets OG5_133504 All targets in OG5_133504
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Onchocerca volvulus Transitional endoplasmic reticulum ATPase homolog 0.1506 1 0.5
Trypanosoma brucei Valosin-containing protein 0.1429 0.9431 0.5
Brugia malayi valosin containing protein 0.0883 0.5427 1
Schistosoma mansoni microtubule-associated protein tau 0.0833 0.5059 0.2381
Loa Loa (eye worm) VCP protein 0.0623 0.3515 0.6476
Trichomonas vaginalis spermatogenesis associated factor, putative 0.1506 1 1
Entamoeba histolytica transitional endoplasmic reticulum ATPase, putative 0.1429 0.9431 0.5
Brugia malayi transitional endoplasmic reticulum ATPase TER94, putative 0.0623 0.3515 0.6476
Toxoplasma gondii cell division protein CDC48CY 0.1506 1 1
Toxoplasma gondii cell division protein CDC48AP 0.0902 0.556 0.0000097958
Loa Loa (eye worm) vesicle-fusing ATPase 0.0883 0.5427 1
Mycobacterium ulcerans ATPase 0.0902 0.556 0.5
Plasmodium vivax cell division cycle protein 48 homologue, putative 0.1429 0.9431 1
Echinococcus multilocularis microtubule associated protein 2 0.0833 0.5059 0.2381
Schistosoma mansoni cell division control protein 48 aaa family protein 0.1429 0.9431 0.9122
Mycobacterium tuberculosis Putative conserved ATPase 0.0902 0.556 0.5
Entamoeba histolytica cdc48-like protein, putative 0.1429 0.9431 0.5
Leishmania major Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog 0.1429 0.9431 0.5
Giardia lamblia AAA family ATPase 0.0902 0.556 0.5
Loa Loa (eye worm) hypothetical protein 0.0883 0.5427 1
Schistosoma mansoni cell division control protein 48 aaa family protein 0.1506 1 1
Plasmodium falciparum cell division cycle protein 48 homologue, putative 0.1429 0.9431 0.5
Brugia malayi vesicle-fusing ATPase 0.0883 0.5427 1
Echinococcus multilocularis transitional endoplasmic reticulum atpase 0.1506 1 1
Trypanosoma cruzi Valosin-containing protein, putative 0.1429 0.9431 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 2.8184 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (binding) = 11.2202 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) 25.1189 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] ChEMBL. No reference
Potency (functional) = 50.1187 um PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.